Plasma ctDNA RAS mutation analysis for the diagnosis and treatment monitoring of metastatic colorectal cancer patients
2017 · Annals of Oncology · 341 citations
https://doi.org/10.1093/annonc/mdx125
J
Joana Vidal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
119
Papers
1.7K
Citations
19
h-index
23
i10-index
Joana Vidal is an academic researcher from Memorial Sloan Kettering Cancer Center. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Colorectal Cancer Treatments and Studies & Lung Cancer Treatments and Mutations. The author has an h-index of 19, co-authored 102 publications.
ORCID: 0000-0002-2560-1203Papers by this author
worksConcordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
2017 · Annals of Oncology · 189 citations
https://doi.org/10.1093/annonc/mdx112
Real-world first-line treatment of patients with BRAFV600E-mutant metastatic colorectal cancer: the CAPSTAN CRC study
2022 · ESMO Open · 26 citations
https://doi.org/10.1016/j.esmoop.2022.100603
Dabrafenib in an elderly patient with metastatic melanoma and BRAF V600R mutation: a case report
2016 · Journal of Medical Case Reports · 11 citations
https://doi.org/10.1186/s13256-016-0953-0
Liquid biopsy, big data and artificial intelligence as a new global clinical trial model in targeted therapy
2023 · The Journal of Liquid Biopsy · 3 citations
https://doi.org/10.1016/j.jlb.2023.100008
LBA33 Circulating tumor (ct) DNA-guided anti-EGFR rechallenge strategy in metastatic colorectal cancer (mCRC): Final results of the phase II randomized CITRIC trial
2025 · Annals of Oncology · 2 citations
https://doi.org/10.1016/j.annonc.2025.09.044
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat